27811060|t|IL-10 prevents aging - associated inflammation and insulin resistance in skeletal muscle
27811060|a|Altered energy balance and insulin resistance are important characteristics of aging. Skeletal muscle is a major site of glucose disposal, and the role of aging - associated inflammation in skeletal muscle insulin resistance remains unclear. To investigate, we examined glucose metabolism in 18-mo-old transgenic mice with muscle - specific overexpression of IL-10 (M(IL10)) and in wild-type mice during hyperinsulinemic-euglycemic clamping. Despite similar fat mass and energy balance, M(IL10) mice were protected from aging - associated insulin resistance with significant increases in glucose infusion rates, whole-body glucose turnover, and skeletal muscle glucose uptake (âˆ¼60%; P < 0.05), as compared to age -matched WT mice. This protective effect was associated with decreased muscle inflammation, but no changes in adipose tissue inflammation in aging M(IL10) mice. These results demonstrate the importance of skeletal muscle inflammation in aging -mediated insulin resistance, and our findings further implicate a potential therapeutic role of anti-inflammatory cytokine in the treatment of aging -mediated insulin resistance .-Dagdeviren, S., Jung, D. Y., Friedline, R. H., Noh, H. L., Kim, J. H., Patel, P. R., Tsitsilianos, N., Inashima, K., Tran, D. A., Hu, X., Loubato, M. M., Craige, S. M., Kwon, J. Y., Lee, K. W., Kim, J. K. IL-10 prevents aging-associated inflammation and insulin resistance in skeletal muscle.
27811060	0	5	IL-10	T116,T129	C0085295
27811060	6	14	prevents	T169	C1292733
27811060	15	20	aging	T040	C0001811
27811060	23	33	associated	T080	C0332281
27811060	34	46	inflammation	T046	C0021368
27811060	51	69	insulin resistance	T046	C0021655
27811060	73	88	skeletal muscle	T024	C0242692
27811060	89	96	Altered	T169	C0392747
27811060	97	111	energy balance	T040	C0597987
27811060	116	134	insulin resistance	T046	C0021655
27811060	139	148	important	T080	C3898777
27811060	149	164	characteristics	T080	C1521970
27811060	168	173	aging	T040	C0001811
27811060	175	190	Skeletal muscle	T024	C0242692
27811060	202	206	site	T029	C1515974
27811060	210	217	glucose	T109,T121,T123	C0017725
27811060	218	226	disposal	T052	C1707797
27811060	244	249	aging	T040	C0001811
27811060	252	262	associated	T080	C0332281
27811060	263	275	inflammation	T046	C0021368
27811060	279	294	skeletal muscle	T024	C0242692
27811060	295	313	insulin resistance	T046	C0021655
27811060	334	345	investigate	T169	C1292732
27811060	359	377	glucose metabolism	T044	C0596620
27811060	391	406	transgenic mice	T015	C0025936
27811060	412	418	muscle	T024	C0026845
27811060	421	429	specific	T080	C0205369
27811060	430	444	overexpression	T045	C1514559
27811060	448	453	IL-10	T116,T129	C0085295
27811060	455	462	M(IL10)	T116,T129	C0085295
27811060	471	485	wild-type mice	T015	C1520150
27811060	486	492	during	T079	C0347984
27811060	493	529	hyperinsulinemic-euglycemic clamping	T060,T062	C0017728
27811060	539	546	similar	T080	C2348205
27811060	547	555	fat mass	T032	C3656665
27811060	560	574	energy balance	T040	C0597987
27811060	576	583	M(IL10)	T116,T129	C0085295
27811060	584	588	mice	T015	C0025929
27811060	594	603	protected	T169	C0439844
27811060	609	614	aging	T040	C0001811
27811060	617	627	associated	T080	C0332281
27811060	628	646	insulin resistance	T046	C0021655
27811060	652	663	significant	T078	C0750502
27811060	664	673	increases	T081	C0205217
27811060	677	684	glucose	T109,T121,T123	C0017725
27811060	685	699	infusion rates	T079	C2964135
27811060	701	711	whole-body	T017	C0444584
27811060	712	719	glucose	T109,T121,T123	C0017725
27811060	720	728	turnover	T081	C0392762
27811060	734	749	skeletal muscle	T024	C0242692
27811060	750	764	glucose uptake	T043	C1159527
27811060	786	794	compared	T052	C1707455
27811060	798	801	age	T032	C0001779
27811060	811	818	WT mice	T015	C0025929
27811060	825	842	protective effect	T080	C1280500
27811060	847	862	associated with	T080	C0332281
27811060	863	872	decreased	T081	C0205216
27811060	873	892	muscle inflammation	T047	C0027121
27811060	898	900	no	T033	C1513916
27811060	901	908	changes	T169	C0392747
27811060	912	926	adipose tissue	T024	C0001527
27811060	927	939	inflammation	T046	C0021368
27811060	943	948	aging	T040	C0001811
27811060	949	956	M(IL10)	T116,T129	C0085295
27811060	957	961	mice	T015	C0025929
27811060	969	976	results	T033	C0683954
27811060	993	1003	importance	T080	C3898777
27811060	1007	1022	skeletal muscle	T024	C0242692
27811060	1023	1035	inflammation	T046	C0021368
27811060	1039	1044	aging	T040	C0001811
27811060	1055	1073	insulin resistance	T046	C0021655
27811060	1083	1091	findings	T033	C0243095
27811060	1112	1121	potential	T080	C3245505
27811060	1122	1133	therapeutic	T169	C0039798
27811060	1134	1138	role	T077	C1705810
27811060	1142	1159	anti-inflammatory	T121	C0003209
27811060	1160	1168	cytokine	T116,T129	C0079189
27811060	1176	1185	treatment	T061	C0087111
27811060	1189	1194	aging	T040	C0001811
27811060	1205	1223	insulin resistance	T046	C0021655